June 26, 2007European Heart Journal131 citationsOpen Access
View Full PaperCardiovascular responses to weight management and sibutramine in high-risk subjects: an analysis from the SCOUT trial
Structured PICO
Is 6-week treatment with sibutramine efficacious, tolerable, and safe in high-risk subjects for whom it is usually contraindicated?
P
Population
High-risk subjects for whom sibutramine is usually contraindicated
I
Intervention
Sibutramine (6-week treatment)
O
Outcome
Efficacy, tolerability, and safetysafety
Six-week treatment with sibutramine appears safe and tolerable in high-risk subjects where it is typically contraindicated.
Abstract
Six-week treatment with sibutramine appears to be efficacious, tolerable and safe in this high-risk population for whom sibutramine is usually contraindicated.